Cardinal Health Inc (CAH) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Consensus $7.86. The company said, “The company raised its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to ...

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

(CAH) on Thursday reported fiscal second-quarter earnings of $400 million. The Dublin, Ohio-based company said it had net income of $1.65 per share. Earnings, adjusted for one-time gains and costs, ...

Dublin City Schools is officially withdrawing from an agreement with Cardinal Health to purchase a vacant office building, Superintendent John Marschhausen told board members at a meeting Monday ...

Cardinal Health (CAH) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.82 per share a year ago. These ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting ...

Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, touching an all-time high of $126.3. According to InvestingPro analysis, the stock remains undervalued despite this milestone ...

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.